Cargando…
MiR‐145 in cancer therapy resistance and sensitivity: A comprehensive review
MircoRNA (miRNA) are a group of small, non–coding, regulatory RNA with an average length of approximately 22 nucleotides, which mostly modulate gene expression post–transcriptionally through complementary binding to the 3ʹ‐untranslated region (3ʹ‐UTR) of multiple target genes. Emerging evidence has...
Autores principales: | Xu, Wenxiu, Hua, Yuting, Deng, Fei, Wang, Dandan, Wu, Yang, Zhang, Wei, Tang, Jinhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469794/ https://www.ncbi.nlm.nih.gov/pubmed/32506767 http://dx.doi.org/10.1111/cas.14517 |
Ejemplares similares
-
miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
por: Gao, Man, et al.
Publicado: (2016) -
The miR-143/miR-145 cluster and the tumor microenvironment: unexpected roles
por: Almeida, Maria Inês, et al.
Publicado: (2016) -
The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease
por: Vacante, Francesca, et al.
Publicado: (2019) -
Effect of miR-145 on gastric cancer cells
por: Wang, Jia, et al.
Publicado: (2019) -
Reversal of glucocorticoid resistance in Acute Lymphoblastic Leukemia cells by miR-145
por: Long, Sili, et al.
Publicado: (2020)